Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Erector Spinae Block vs Paravertebral Block for Chronic Pain After Mastectomy

Official title: The Effect of Erector Spinae Block Versus Paravertebral Block on the Incidence of Chronic Pain After Mastectomy: A Randomized Controlled Trial

Run by American University of Beirut Medical Center · NCT07561411 · Data updated 2026-11-12

This trial tests whether an erector spinae block can better prevent chronic pain after mastectomy than a paravertebral block in adults 18–80.

More Opioid Use trials

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment132 (estimated)
SponsorAmerican University of Beirut Medical Center
Academic / other
Locations1 site (Beirut)
StatusRecruiting
StartedMay 19, 2026
Main results expectedMay 1, 2028
Study endsMay 1, 2028
Registry record updatedJune 2, 2026
Trial IDNCT07561411 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–80 undergoing total mastectomy (with or without axillary dissection), ASA 1–3, eligible for regional anesthesia in addition to general anesthesia.

Probably not a fit

Patients with contraindications to regional blocks, chronic pain or severe depression, ASA 4+, or those not receiving regional anesthesia may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, interventional trial compares two regional anesthesia techniques—erector spinae block and paravertebral block—in adults undergoing total mastectomy with or without axillary dissection. The study seeks to determine if the erector spinae block lowers the incidence of chronic pain at 3 months and influences perioperative outcomes such as opioid use, early pain scores, block performance time, and short-term complications or mood symptoms. Enrollment targets 132 participants (66 per group) at the American University of Beirut Medical Center. Participants are adults aged 18–80, ASA 1–3, scheduled for mastectomy and willing to receive regional anesthesia in addition to general anesthesia. Exclusion criteria include prior thoracic surgery with large incisions, allergy to local anesthetics, pregnancy, significant coagulopathy, ASA 4+, or history of chronic pain or untreated depression.

Why it matters

Potential benefit: If successful, patients may experience less chronic pain after mastectomy and lower perioperative opioid needs.

How similar studies have gone: Prior evidence suggests regional blocks can reduce acute/postoperative pain; this study tests equivalence or superiority of ESB versus PVB for chronic pain outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patients between 18 and 80 years old.
* Scheduled to total mastectomy with or without axillary dissection
* Willing to receive regional anesthesia in addition to GA
* ASA classification 1-3

Exclusion Criteria:

* Previous thoracic surgery with an incision of \>2 cm
* Patient's refusal
* Allergy to local anesthetics
* Pregnant women
* Any contraindications to thoracic PVB, including intrathoracic infection, infection at the puncture site, cancer invasion of the puncture site, severe spinal deformity, history of spinal surgery, and severe coagulopathy; anticoagulants intake.
* American Society of Anesthesiologists (ASA) classification of 4 or higher,
* History of chronic pain or untreated clinical severe depression

Where it's running

  • American University of Beirut Medical Center
    Beirut, Lebanon
    Recruiting

Study contacts

  • Principal investigator: Nancy Abou Nafeh, MD — American University of Beirut Medical Center
  • Study coordinator: Nancy Abou Nafeh, MD
  • Email: na181@aub.edu.lb
  • Phone: 01350000

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.